Vasoplegia clinical trials at UCSF
1 research study open to eligible people
Vasoplegia is when blood pressure drops too low. UCSF is doing a study about a drug called Angiotensin II and its safety when used as a second-line option during liver transplantation. The study will test how well Angiotensin II works as a vasopressor, which raises blood pressure.
open to eligible people ages 18 years and up
The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.
San Francisco, California
Our lead scientists for Vasoplegia research studies include Michael P Bokoch, M.D., Ph.D..